期刊文献+

肾移植患者术后股骨头坏死临床研究 被引量:3

Clinical study on avuscular necrosis of femoral head after renal transplantation
下载PDF
导出
摘要 目的探讨肾移植术后股骨头坏死的发病情况及相关因素。方法对572例接受肾移植的患者进行普查,观察患者术前的透析时间、糖皮质激素量(静脉及口服)及时间、股骨头坏死发病时间。结果415名患者得到随诊,共发现4例股骨头坏死患者,皆为双侧,患病率为0.98%,平均发病时间为6.25个月,患者术后前3d静脉甲基强的松龙的平均用量是(2841.47±967.92)mg,第1年(2990.60±1078.45)mg,第1个月口服强的松的平均剂量是(763.10±125.76)mg,第1年为(4831.27±693.88)mg。结论肾移植术后股骨头坏死的患病率低,主要原因是激素在抗免疫治疗中的比重降低,冲击治疗时间短,降血脂及时。患病原因和糖皮质激素及个体对糖皮质激素的敏感度差异有关。 [Objective] To analyze the prevalance and risk factors of avuscular necrosis of femoralhead(ANFH) after renal transplantation. [Methods] Investagated 572 renal transplantation recipients, observed the dialysis duration pre-transplant,dose and duration of corticoid,time from transplantation to onset of joint pain. [Results] 412 patients were followed up, 4 (0.98%) were found to be ANFH, all suffered both femoral head, mean duration of ocurrence is 6.25 months, the mean dose of methylprednisolone for 3 days post-operation is (2841.47±967.92) mg, and (2990.60±1078.45) mg for first year,the mean dose of prednisone for first month is (763.10±125.76) mg, and (4831.27±693.88) mg for first year. [Conclusion] This study showed low prevalence of ANFH after renal transplantation, the major reason is low proportion of corticoid, short time of large dose corticoid therpy, control of lipemia. Corticoid and idiosyncrasy to the corticoid in individual bases may related to ANFH.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第10期1406-1408,1412,共4页 China Journal of Modern Medicine
关键词 股骨头坏死 肾移植 患病率 avascular necrosis of femoral head renal transplantation prevalence
  • 相关文献

参考文献1

二级参考文献16

  • 1Weaver C J, Major NM, Garrett WE, et al. Femoral head osteochondral lesions in painful hips of athletes: MR imaging findings. AJR Am J Roentgenol, 2002, 178 : 973-977.
  • 2Fujioka M, Kubo T, Nakamura F, et al. Initial changes of nontraumatic osteonecrosis of femoral head in fat suppression images: bone marrow edema was not found before the appearance of band patterns. Magn Roson Imaging, 2001, 19: 985-991.
  • 3Nishii T, Sugano N, Ohzono K, et al. Significance of lesion size and location in the prediction of collapse of osteonecrosis of the femoral head : a new three-dimensional quantification using magnetic resonance imaging. J Orthop Res,2002, 20: 130-136.
  • 4Koo KH, Kim R. Quantifying the extent of osteonecrosis of the femoral head: a new method using MRI. J Bone Joint Surg Br,1995, 77: 875-880.
  • 5Piettogrand V, Mastromarino R. Osteopatda prolungata trattamento cortisonico. Ortop Traum Appar Mar, 1957, 25 : 791-10.
  • 6Hirota Y, Hotokebuchi T, Sugioka Y. Epidemiologic Survey on idiopathic osteonecrosis of the femoral head in Japan. In: Urbaniak JR and Jones JP, et al. Osteonecrosis : etiology, diagnisis, and treatment. Rosemout IL : American Academy of Orthopaedic Surgeons, 1997.39-44.
  • 7Lieberman JR, Berry DJ, Mont MA, et al. Osteonecrosis of the hip: management in the twenty-first century. J Bone Joint Surg Am,2002, 84:834-853.
  • 8Felson DT, Anderson JJ. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet,1987, (8538) : 902-906.
  • 9Jones LC, Hungerford DS. Overview of osteonecrosis of the hip and current treatment options. Curr Opin Orthop, 2003, 14: 12-16.
  • 10Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am,1995, 77: 459-474.

共引文献74

同被引文献25

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部